West Nile Screening Is Only First Step To Broader Virus Protection – Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes that efforts to develop a blood screening assay for West Nile virus will lead to technology that can be adapted to screen for other rare, endemic flaviviruses